Christopher D. Ozeroff
2017
In 2017, Christopher D. Ozeroff earned a total compensation of $438.3K as Secretary, Senior Vice President and General Counsel at ARCA biopharma, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $53,500 |
|---|---|
| Option Awards | $76,654 |
| Salary | $296,011 |
| Other | $12,110 |
| Total | $438,275 |
Ozeroff received $296K in salary, accounting for 68% of the total pay in 2017.
Ozeroff also received $53.5K in non-equity incentive plan, $76.7K in option awards and $12.1K in other compensation.
Rankings
In 2017, Christopher D. Ozeroff's compensation ranked 12,318th out of 14,666 executives tracked by ExecPay. In other words, Ozeroff earned more than 16.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,318 out of 14,666 | 16th |
Division Manufacturing | 4,848 out of 5,772 | 16th |
Major group Chemicals And Allied Products | 1,778 out of 2,075 | 14th |
Industry group Drugs | 1,476 out of 1,731 | 15th |
Industry In Vitro and In Vivo Diagnostic Substances | 60 out of 72 | 17th |
Source: SEC filing on April 18, 2018.
Ozeroff's colleagues
We found two more compensation records of executives who worked with Christopher D. Ozeroff at ARCA biopharma in 2017.
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019